Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Organogenesis Holdings (ORGO) Deferred Taxes (2023 - 2025)

Organogenesis Holdings has reported Deferred Taxes over the past 3 years, most recently at $13.5 million for Q4 2025.

  • Quarterly results put Deferred Taxes at $13.5 million for Q4 2025, up 575.07% from a year ago — trailing twelve months through Dec 2025 was $7.3 million (changed N/A YoY), and the annual figure for FY2025 was $7.3 million, up 168.34%.
  • Deferred Taxes for Q4 2025 was $13.5 million at Organogenesis Holdings, up from -$3.8 million in the prior quarter.
  • Over the last five years, Deferred Taxes for ORGO hit a ceiling of $13.5 million in Q4 2025 and a floor of -$3.8 million in Q3 2025.
  • Median Deferred Taxes over the past 3 years was -$1.3 million (2025), compared with a mean of $800857.1.
  • Biggest five-year swings in Deferred Taxes: crashed 185.53% in 2024 and later soared 575.07% in 2025.
  • Organogenesis Holdings' Deferred Taxes stood at $3.3 million in 2023, then tumbled by 185.53% to -$2.8 million in 2024, then soared by 575.07% to $13.5 million in 2025.
  • The last three reported values for Deferred Taxes were $13.5 million (Q4 2025), -$3.8 million (Q3 2025), and -$1.0 million (Q2 2025) per Business Quant data.